Y Bai, W Wang, P Yin, J Gao, L Na, Y Sun… - … Journal of Biological …, 2020 - ncbi.nlm.nih.gov
Ruxolitinib is a selective inhibitor of Jak1/2. Downstream signaling pathways of Jak, such as
Stat3 and Akt/mTOR, are overactivated and contribute to renal interstitial fibrosis. Therefore …